Cyclin D1 is a candidate oncogene in cutaneous melanoma

Cancer Research

Volumn 62, Issue 11, 2002, Pages 3200-3206

  Yeo, Un Cheol ^a   Von Stemm, Andrea ^a   Bastian, Boris C ^a,b   Pinkel, Dan ^b   Sauter, Edward R ^c,d   Tichansky, David S ^c   Pistritto, Giuseppa ^c   Nesbit, Mark ^c   Herlyn, Meenhard ^c   Zhu, Weizhu ^d   Litwin, Samuel ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WISTAR INSTITUTE   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CYCLIN D1;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT LENTIGO; MELANOCYTE; MELANOMA; NICK END LABELING; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINOBLASTOMA;

APOPTOSIS; CELL DIVISION; CYCLIN D1; GENE AMPLIFICATION; GENE DOSAGE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MELANOMA; ONCOGENES; SKIN NEOPLASMS; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0036605974     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. A
2. A
3. A
4. A
5. A
6. A
7. A
8. A
9. A
10. A
11. A
12. A
13. A
14. A
15. A
16. A
17. A
18. A
19. A
20. A
21. A
22. A
23. A
24. A
25. A
26. A
27. A
28. A
29. A
30. A
31. A
32. A
33. A
34. A
35. A
36. A
37. A
38. A
39. A